Wholesome Wellness sells Natural Anxiety & Depression Relief with website claims that make it an unapproved new drug.
What happened
FDA reviewed www.wholesome-wellness.com in December 2020 and found the company takes orders there for Natural Anxiety & Depression Relief. FDA said website claims, including a label image saying it helps fight against depression and herb descriptions, show the product is intended to treat disease, making it an unapproved new drug. FDA also said the product lacks adequate directions for use and is therefore misbranded.
What FDA found
FDA says the website claims show the product is intended to treat disease, so FDA treats it as a drug.
21 U.S.C. § 321(g)(1)(B)FDA says the product is a new drug without FDA approval and is not generally recognized as safe and effective for the claimed uses.
21 U.S.C. § 321(p); 21 U.S.C. § 355(a)FDA says the product is misbranded because it lacks adequate directions for a layperson to use it safely.
21 U.S.C. § 352(f)(1); 21 C.F.R. § 201.5FDA says introducing or delivering the product into interstate commerce violates the Act.
21 U.S.C. § 331(a); 21 U.S.C. § 331(d)
What FDA wants
FDA asks the company to notify it in writing within 15 working days of receipt of the specific steps taken to fix the violations and prevent recurrence, with supporting documents. If the company disagrees, it should explain why and send the reply to FDAAdvisory@fda.hhs.gov.
Who should pay attention
- companies selling herbal or supplement products with disease-treatment claims
- online retailers that list such products
- regulatory teams reviewing website and label claims
This is a summary. Read the original letter on fda.gov.